Stem Cell Manufacturing Market Report 2023, Size, Share And forecast Till 2028

Byimarcsuraj

IMARC Group has recently released a new research study “Stem cell manufacturing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

What Are The Growth Prospects Of The Stem Cell Manufacturing Industry?

The global stem cell manufacturing market size reached us$ 12.3 billion in 2022. looking forward, imarc group expects the market to reach a value of US$ 19.9 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.

What Is A Stem Cell Manufacturing?

Stem cells represent undifferentiated or partially differentiated cells that make up the tissues and organs of animals and plants. They are commonly sourced from blood, bone marrow, umbilical cord, embryo, and placenta. Under the right body and laboratory conditions, stem cells can divide to form more cells, including red blood cells (RBCs), platelets, and white blood cells, which generate specialized functions. Stem cells are widely used for human disease modeling, drug discovery, development of cell therapies for untreatable diseases, gene therapy, and tissue engineering. Consequently, they are also utilized to replace damaged organs and tissues and treat numerous diseases.

What Are The Major Market Drivers In The Stem Cell Manufacturing Market?

The inflating venture capital (VC) investments in stem cell research, on account of the increasing awareness about the therapeutic potency of these cells, are among the key factors stimulating the stem cell manufacturing market. Moreover, the widespread adoption of partially differentiated cells in effective disease management, personalized medicine, and genome testing applications is acting as another significant growth-inducing factor. Besides this, the incorporation of three-dimensional (3D) printing and microfluidic technologies to reduce production time and lower cost by integrating several production steps into one device is positively influencing the global market.

Request And Get A Sample Brochure For Free: https://www.imarcgroup.com/stem-cell-manufacturing-market/requestsample

Furthermore, the rising utilization of stem cells in the pharmaceutical sector for manufacturing hematopoietic stem cells (HSC)- and mesenchymal stem cells (MSC)-based drugs for treating tumors, leukemia, and lymphoma is also propelling the market growth. Apart from this, the increasing application of undifferentiated cells in research applications to produce new drugs that aid in improving functions and altering the progress of diseases is further fueling the global market. Additionally, the growing usage of the technique in tissue and organ replacement therapies, significant improvements in medical infrastructures, and the launch of various government initiatives promoting public health are anticipated to fuel the stem cell manufacturing market over the forecasted period.

Who Are The Key Players/Companies In Stem Cell Manufacturing Market?

Anterogen Co. Ltd., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Corning Incorporated, FUJIFILM Holdings Corporation, Lonza Group AG, Merck KGaA, Sartorius AG, Takara Bio Inc. and Thermo Fisher Scientific Inc.

Report Segmentation:

The report has been segmented the market into following categories:

Breakup by Product:

  • Consumables
    • Culture Media
    • Others
  • Instruments
      • Bioreactors and Incubators
      • Cell Sorters
      • Others

  • Stem Cell Lines
    • Hematopoietic Stem Cells (HSC)
    • Mesenchymal Stem Cells (MSC)
    • Induced Pluripotent Stem Cells (iPSC)
    • Embryonic Stem Cells (ESC)
    • Neural Stem Cells (NSC)
    • Multipotent Adult Progenitor Stem Cell

Breakup by Application:

  • Research Applications
    • Life Science Research
    • Drug Discovery and Development
  • Clinical Application
    • Allogenic Stem Cell Therapy
    • Autologous Stem Cell Therapy
  • Cell and Tissue Banking Applications

Breakup by End User:

  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes, Research Laboratories and Contract Research Organizations
  • Hospitals and Surgical Centers
  • Cell and Tissue banks
  • Others

Regional Insights:

  • Asia Pacific
  • North America
  • Europe
  • Middle East and Africa
  • Latin America

On the geographical front, Asia Pacific enjoys the leading position in the market. This can be attributed to the rising establishment of international companies in the region, on account of low manufacturing costs and cheap labor.

Ask An Analyst: https://www.imarcgroup.com/request?type=report&id=6072&flag=C

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.

30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 |

Africa and Europe :- +44-702-409-7331 |

Asia: +91-120-433-0800, +91-120-433-0800